- Best in Class distinctions for Overall Staff, Cultural Fit, Technology Use, and Scaling Support.
- Recognition within the Samall/Mid-Size Small Molecule API group.
Barcelona, March 30, 2026 – AGC Pharma Chemicals has been honored with four Best in Class distinctions in the CDMO Leadership Awards 2026, within the Small/Mid-Size Small Molecule API group: Overall Staff, Cultural Fit, Technology Use, and Scaling Support.
Presented by Outsourced Pharma and Life Science Connect, the CDMO Leadership Awards are widely regarded as one of the most important recognitions in the CDMO sector, as they are grounded in independent customer feedback from leaders across the biopharmaceutical and biotechnology industries. The awards highlight CDMOs that stand out not only for technical delivery, but also for the overall working experience customers have across the lifecycle of outsourced projects.
The Best in Class distinction for Overall Staff reflects the value customers place on strong, responsive teams and effective day-to-day collaboration in complex API programs. The recognition for Cultural Fit underscores the importance of a partner that integrates smoothly with client teams, communicates clearly, and supports shared decision-making.
In addition, the Best in Class award for Technology Use emphasizes the role of enabling systems and modern tools in strengthening development and manufacturing execution. Finally, being honored for Scaling Support highlights the capability to support evolving program needs as projects progress and scale requirements increase.
As a global CDMO specializing in Active Pharmaceutical Ingredients (APIs) and intermediates, with facilities in Spain (Barcelona) and Japan, AGC Pharma Chemicals remains focused on delivering reliable execution, quality, and scalable support for small molecule API programs—helping customers move forward with confidence from development through commercialization.
